skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry
Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry

McCombs, Jessica R. ; Owen, Shawn C.

The AAPS journal, 2015-03, Vol.17 (2), p.339-351 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
2
Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study
Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study

Lonial, Sagar ; Lee, Hans C. ; Badros, Ashraf ; Trudel, Suzanne ; Nooka, Ajay K. ; Chari, Ajai ; Abdallah, Al‐Ola ; Callander, Natalie ; Sborov, Douglas ; Suvannasankha, Attaya ; Weisel, Katja ; Voorhees, Peter M. ; Womersley, Lynsey ; Baron, January ; Piontek, Trisha ; Lewis, Eric ; Opalinska, Joanna ; Gupta, Ira ; Cohen, Adam D.

Cancer, 2021-11, Vol.127 (22), p.4198-4212 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
Hodgkin lymphoma: A review and update on recent progress
Hodgkin lymphoma: A review and update on recent progress
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hodgkin lymphoma: A review and update on recent progress

Shanbhag, Satish ; Ambinder, Richard F.

CA: a cancer journal for clinicians, 2018-03, Vol.68 (2), p.116-132 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
4
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I

Moore, K.N. ; Oza, A.M. ; Colombo, N. ; Oaknin, A. ; Scambia, G. ; Lorusso, D. ; Konecny, G.E. ; Banerjee, S. ; Murphy, C.G. ; Tanyi, J.L. ; Hirte, H. ; Konner, J.A. ; Lim, P.C. ; Prasad-Hayes, M. ; Monk, B.J. ; Pautier, P. ; Wang, J. ; Berkenblit, A. ; Vergote, I. ; Birrer, M.J.

Annals of oncology, 2021-06, Vol.32 (6), p.757-765 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity
Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity

Ogitani, Yusuke ; Hagihara, Katsunobu ; Oitate, Masataka ; Naito, Hiroyuki ; Agatsuma, Toshinori

Cancer science, 2016-07, Vol.107 (7), p.1039-1046 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
6
Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates
Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates
Material Type:
Artigo 		Adicionar ao Meu Espaço

Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates

Matsuda, Yutaka ; Mendelsohn, Brian A.

Chemical and Pharmaceutical Bulletin, 2021/10/01, Vol.69(10), pp.976-983 [Periódico revisado por pares]

Tokyo: The Pharmaceutical Society of Japan

Texto completo disponível

Citações Citado por
7
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

Bardia, A. ; Messersmith, W.A. ; Kio, E.A. ; Berlin, J.D. ; Vahdat, L. ; Masters, G.A. ; Moroose, R. ; Santin, A.D. ; Kalinsky, K. ; Picozzi, V. ; O'Shaughnessy, J. ; Gray, J.E. ; Komiya, T. ; Lang, J.M. ; Chang, J.C. ; Starodub, A. ; Goldenberg, D.M. ; Sharkey, R.M. ; Maliakal, P. ; Hong, Q. ; Wegener, W.A. ; Goswami, T. ; Ocean, A.J.

Annals of oncology, 2021-06, Vol.32 (6), p.746-756 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities
Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities
Material Type:
Artigo 		Adicionar ao Meu Espaço

Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities

Manning-Geist, Beryl L. ; Sullivan, Mackenzie W. ; Zhou, Qin ; Iasonos, Alexia ; Selenica, Pier ; Stallworth, Chrystal ; Liu, Ying L. ; Long Roche, Kara ; Gordhandas, Sushmita ; Aghajanian, Carol ; Chi, Dennis ; O'Cearbhaill, Róisín ; Grisham, Rachel N. ; Chui, M. Herman

Gynecologic oncology, 2024-09, Vol.188, p.52-57 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
9
Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma
Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma

Abeykoon, Jithma P. ; Vaxman, Julia ; Patel, Sanjay V. ; Kumar, Shaji ; Malave, Gabriella C. ; Young, Kimberly S. ; Ailawadhi, Sikander ; Larsen, Jeremy T. ; Dispenzieri, Angela ; Muchtar, Eli ; Gonsalves, Wilson I. ; Kourelis, Taxiarchis ; Leung, Nelson ; Warsame, Rahma ; Go, Ronald S. ; Bergsagel, Leif ; Lacy, Martha Q. ; Rajkumar, S. Vincent ; Gertz, Morie A. ; Kapoor, Prashant

British journal of haematology, 2022-10, Vol.199 (1), p.95-99 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
Targeting cancer with antibody-drug conjugates: Promises and challenges
Targeting cancer with antibody-drug conjugates: Promises and challenges
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting cancer with antibody-drug conjugates: Promises and challenges

Dean, Alexis Q. ; Luo, Shen ; Twomey, Julianne D. ; Zhang, Baolin

mAbs, 2021-01, Vol.13 (1), p.1951427 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (2.304)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (2.540)
  2. Book Chapters  (72)
  3. Reports  (66)
  4. Newsletter Articles  (43)
  5. magazinearticle  (26)
  6. Dissertações  (24)
  7. Livros  (23)
  8. Conjunto de Dados  (20)
  9. Verbetes  (4)
  10. Resenhas  (3)
  11. Anais de Congresso  (3)
  12. Web Resources  (1)
  13. Mais opções open sub menu

Idioma 

  1. Inglês  (2.772)
  2. Japonês  (301)
  3. Chinês  (15)
  4. Alemão  (13)
  5. Francês  (12)
  6. Português  (3)
  7. Coreano  (2)
  8. Polonês  (1)
  9. Russo  (1)
  10. Norueguês  (1)
  11. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.